Glendon E. French III, Director at Pulmonx Corp (LUNG), sold 4,547 shares at $6.53 ($30K) on 2025-01-16, disclosed to the SEC on 2025-01-21.
Scheduled sale ($30k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.53 | 2,326 | $15K | 51.3% |
| 2 | $6.50 | 2,221 | $14K | 48.7% |
| Total | $6.52 avg | 4,547 | $30K | 100% |
| Filing → |
| LUNG | SELL | 2026-03-04 | $97K | — | Filing → |
| LUNG | SELL | 2025-12-03 | $14K | — | Filing → |
| LUNG | SELL | 2025-03-21 | $157K | — | Filing → |